Literature DB >> 6385004

Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells.

D A Cheresh, J R Harper, G Schulz, R A Reisfeld.   

Abstract

The predominant gangliosides produced by two cultured human melanoma cell lines are GD3 and/or GD2. These gangliosides were found to be cell associated and present in substratum-attached material after cell removal by EDTA. Monoclonal antibodies directed to GD2 and GD3 specified the cell-surface distribution of these gangliosides and localized them in focal adhesion plaques at the interface of cells and their substratum. These attachment sites did not represent indiscriminant membrane fragments remaining after removal of cells with EDTA, because neither melanoma-associated proteoglycan nor class I histocompatibility antigens were detected by their respective antibodies. Our data suggest that the disialogangliosides GD2 and GD3 may be involved in the interaction between human melanoma cells and solid substrata.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6385004      PMCID: PMC391792          DOI: 10.1073/pnas.81.18.5767

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Release of macromolecules from BALB-c mouse cell lines treated with chelating agents.

Authors:  L A Culp; P H Black
Journal:  Biochemistry       Date:  1972-05-23       Impact factor: 3.162

2.  The sialic acids. XI. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides.

Authors:  G W Jourdian; L Dean; S Roseman
Journal:  J Biol Chem       Date:  1971-01-25       Impact factor: 5.157

3.  Incorporation of asialo GM2 and gangliosides in cell surface of cultured metastatic and nonmetastatic BALB/3T3 cell lines: subcutaneous tumor cell take.

Authors:  G Yogeeswaran
Journal:  J Natl Cancer Inst       Date:  1981-02       Impact factor: 13.506

4.  Detection of gangliosides that bind cholera toxin: direct binding of 125I-labeled toxin to thin-layer chromatograms.

Authors:  J L Magnani; D F Smith; V Ginsburg
Journal:  Anal Biochem       Date:  1980-12       Impact factor: 3.365

5.  Colorectal carcinoma antigens detected by hybridoma antibodies.

Authors:  H Koprowski; Z Steplewski; K Mitchell; M Herlyn; D Herlyn; P Fuhrer
Journal:  Somatic Cell Genet       Date:  1979-11

6.  Ganglioside and rabbit erythrocyte membrane receptor for staphylococcal alpha-toxin.

Authors:  I Kato; M Naiki
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

7.  Adhesion plaques of Rous sarcoma virus-transformed cells contain the src gene product.

Authors:  L R Rohrschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

8.  Monoclonal antibody to a plasma membrane antigen of neurons.

Authors:  G S Eisenbarth; F S Walsh; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

9.  GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.

Authors:  C S Pukel; K O Lloyd; L R Travassos; W G Dippold; H F Oettgen; L J Old
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

10.  Inhibition of fibronectin-mediated adhesion of hamster fibroblasts to substratum: effects of tunicamycin and some cell surface modifying reagents.

Authors:  T D Butters; V Devalia; J D Aplin; R C Hughes
Journal:  J Cell Sci       Date:  1980-08       Impact factor: 5.285

View more
  42 in total

1.  Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin.

Authors:  C J Honsik; G Jung; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: a pilot trial.

Authors:  S C Grant; L Kostakoglu; M G Kris; S D Yeh; S M Larson; R D Finn; H F Oettgen; N V Cheung
Journal:  Eur J Nucl Med       Date:  1996-02

3.  Number of sialic acid residues in ganglioside headgroup affects interactions with neighboring lipids.

Authors:  Shelli L Frey; Ka Yee C Lee
Journal:  Biophys J       Date:  2013-09-17       Impact factor: 4.033

4.  Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.

Authors:  K Kitamura; P O Livingston; S R Fortunato; E Stockert; F Helling; G Ritter; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

Authors:  P O Livingston; E J Natoli; M J Calves; E Stockert; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 6.  Cancer vaccine with mimotopes of tumor-associated carbohydrate antigens.

Authors:  Danuta Kozbor
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

7.  Gangliosides regulate tumor cell adhesion to collagen.

Authors:  Tamara Kazarian; Adnan A Jabbar; Fei-Qui Wen; Dharmesh A Patel; Leonard A Valentino
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

8.  Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.

Authors:  D C Longee; C J Wikstrand; J E Månsson; X He; G N Fuller; S H Bigner; P Fredman; L Svennerholm; D D Bigner
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 9.  Ganglioside GD3: structure, cellular distribution, and possible function.

Authors:  T N Seyfried; R K Yu
Journal:  Mol Cell Biochem       Date:  1985-09       Impact factor: 3.396

10.  Antitumor effects of a novel monoclonal antibody with high binding affinity to ganglioside GD3.

Authors:  S Ohta; A Honda; Y Tokutake; H Yoshida; N Hanai
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.